According to #TechSci Research report, India Anti-Fungal Drugs Market is expected to reach US$ 1562.73 million, growing at a double digit CAGR of 10.49% by FY2027. Gain More Insight: https://bit.ly/3ph73aO Get Sample Report: https://bit.ly/3vks6KJ Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
FY2017 – FY2027
INDIA ANTI-FUNGAL DRUGS MARKET
FORECAST & OPPORTUNITIES

2. 2
© TechSci Research
Scope of Report
Product of Interest (POI): Anti-Fungal Drugs
Review Period
FY2017 – FY2020
Base Year
FY2021
Estimated Year
FY2022
Forecast Period
FY2023 – FY2027
Year Range
An antifungal medication, also known as an antimycotic medication, is a pharmaceutical
fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm,
candidiasis, serious systemic infections such as cryptococcal meningitis, and others.
Market Segmentation
REGION
• North
• East
• West
• South
DISTRIBUTION CHANNEL
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy
INFECTION TYPE
• Superficial Fungal Infection
• Systemic Fungal Infection
ROUTE OF ADMINSTRATION
END USER
• Parenteral
• Topical
• Oral
• Others
• Homecare
• Hospitals
• Clinics
• Others
DRUG CLASS
• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others
INDICATION
• Candidiasis
• Aspergillosis
• Dermatophytosis
• Mucormycosis
• Others

3. 3
Table of Contents
S. No. Contents Page No.
1.
Product Overview (A brief description of the category and product inclusions considered under the
scope of the study to give clear picture to the client about the product of interest.)
2.
Research Methodology (A detailed methodology on how we have derived the market related
information and what are the measures that has been taken to validate the data.)
3. Impact of COVID-19 on India Anti-Fungal Drugs Market
4. Executive Summary (This chapter covers summary of the complete study.)
5. Voice of Customer
6.
India Anti-Fungal Drugs Market Outlook, FY2017-FY2027F (This chapter includes a brief overview
of the product of interest market such as total market’s growth rate, expected growth rate, key
growth levers, leading region, top grossing product types, etc. It includes more of a qualitative
information about the market.)
6.1.
Market Size & Forecast(This chapter would include the market size i.e., the revenue generated
from the India Anti-Fungal Drugs market in one year. In this case, the market size will be
provided in value terms for historic period (FY2017-FY2020); current/base year (FY2021);
estimated year (FY2022E); and forecast (FY2023-FY2027))
6.1.1. By Value
6.2.
Market Share & Forecast (The overall product of interest bifurcated/split among various
segments. )
6.2.1. By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others)
6.2.2. By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others)
6.2.3. By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection)
6.2.4. By Route of Administration (Parenteral, Topical, Oral, Others)

4. 4
S. No. Contents Page No.
6.2.5. By End-User (Homecare, Hospitals, Clinics, Others)
6.2.6. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)
6.2.7. By Company (FY2021)
6.2.8. By Top 10 States
6.2.9. By Region
6.3. Product Market Map
7. India Azoles Anti-Fungal Drugs Market Outlook, FY2017-FY2027F
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Infection Type
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Distribution Channel
8. India Echinocandins Anti-Fungal Drugs Market Outlook, FY2017-FY2027F
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
Table of Contents

5. 5
S. No. Contents Page No.
8.2.2. By Infection Type
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Distribution Channel
9. India Polyenes Anti-Fungal Drugs Market Outlook, FY2017-FY2027F
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Infection Type
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Distribution Channel
10. India Allylamines Anti-Fungal Drugs Market Outlook, FY2017-FY2027F
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Infection Type
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Distribution Channel
Table of Contents

6. 6
S. No. Contents Page No.
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. India Economic Profile
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles (Includes SWOT Analysis)
14.2.1. Company Details
14.2.2. Products & Services
14.2.3. Financials (As Reported)
14.2.4. Key Market Focus & Geographical Presence
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15.
Strategic Recommendations (Based on the findings of the report strategic recommendations on how
to enter and expand market share)
16. About Us & Disclaimer
Table of Contents

7. RESEARCH
METHODOLOGY

8. 8
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
India anti-fungal drugs
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
India anti-fungal drugs
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

9. 9
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of India anti-fungal drugs market. The team has
market, while considering the major influencing factors such as rising demand for anti-fungal drugs. The study includes market
decisions while planning their strategy to achieve sustainability in India anti-fungal drugs market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value : Market size, in terms of value , for the year FY2021 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as stainless-steel
and other industry participants.
• The team interviewed more than 15-20 anti-fungal drugs market companies, 100 – 120 end use industries, and 15 – 20 industry
anti-fungal drugs market to obtain the overall market size for FY2017-FY2021, which was validated by the Delphi technique. Taking
size was averaged out, to arrive at the market size data for FY2017-FY2021.
• Respondents were asked about the current and future market growth rates, market shares by drug class, by indication, by infection
distribution channel, by region and by company. Removing the outlier responses, the geometric mean of growth estimates and
various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were

10. 10
Research Methodology
Methodology Followed for Calculation of Market Shares:
• Market shares by drug class, by indication, by infection type, by route of administration, by end user, by distribution channel, by
responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or
anti-fungal drugs market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India
various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

11. 11
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short,
medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market
share data.
Partial List of Companies Interviewed Key Secondary Types
 Pfizer India Ltd.
 Cipla Ltd.
 Glenmark Pharmaceuticals Ltd.
 Sun Pharmaceuticals Industries Ltd.
 Dr. Reddy’s Laboratories Ltd.
 .Viatris Inc. (Mylan NV)
 Lupin Ltd.
 Zydus Cadila Ltd.
 Novartis India Ltd.
 Torrent Pharmaceuticals Ltd.
 Teva Pharmaceutical Industries Ltd
 Janssen Pharmaceuticals Inc. (Johnson & Johnson)
 Abbott Laboratories Ltd.
 GlaxoSmithKline Plc
 Bayer AG
 Dabur India Ltd
 Bharat Serums & Vaccines Ltd
 BDR Pharmaceuticals Internationals Pvt. Ltd.
 Lifecare Innovations Pvt. Ltd.
 Mankind Pharma Ltd
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

12. 12
© TechSci Research
Industry Brief
According to TechSci Research report, “India Anti-Fungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others) By Indication (Mucormycosis,
Dermatophytosis, Aspergillosis, Candidiasis, Others (Cryptococcosis, Coccidioidomycosis) By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection) By Route
of Administration (Oral, Topical, Parenteral, Others) By End-User (Hospitals, Homecare, Specialty Clinics, Others) By Distribution Channel (Hospital Pharmacy, Online
Pharmacy, Retail Pharmacy) By Company, By Region, Forecast & Opportunities, FY2027”, The India anti-fungal drugs market is expected to witness steady growth for the next
five years. Fungi are defined as microorganisms which can cause variety of infections such as growth of the superficial itchy skin upon contact with human body. These kind of
infections takes place due to the presence of low immune systems or exposure to unhygienic environment containing fungus to the human body. Fungal infections generally
occur on skin, hair and lungs and affects the body adversely. Anti-fungal drugs are used for treatment of these infections. These anti-fungal drugs can be easily obtained either
through over the counter or through doctor’s prescription. Surge in number of infectious diseases due to presence of unhygienic conditions in rural areas is accelerating the
demand for anti-fungal drugs in India. Treatment in healthcare facilities can lead to hospital-acquired diseases such as nosocomial infections. Also, the other responsible for
nosocomial infections are increasing prevalence of cancer and other diseases which lowers the immune system of patients.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities of India
imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from
shortness of breath along with coughing and sneezing. India authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting
admitted into the hospital facilities. Patients suffering from COVID-19 found to have small amounts of Interferon’s in lungs or blood. Anti-fungal drugs along with anti-depressant
drugs are used widely for treatment of patients which is expected to positively influence the market growth.
However, stringent government regulations for approval of drugs and long-term usage of drugs along with rising side-effects may hamper the anti-fungal market growth for the
forecast period.
India anti-fungal drugs market is segmented into drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.
Based on indication, market is further divided into mucormycosis, dermatophytosis, aspergillosis, candidiasis, and others. The dermatophytosis segment is expected to dominate
the market for the forecast period, FY2023-FY2027. Increase in occurrence of dermatophytosis across India and presence of unhygienic environmental conditions is fueling the
growth of the anti-fungal drugs market growth. Based on route of administration, anti-fungal drugs market is majorly classified into oral, topical, parenteral and others. The topical
segment is anticipated to witness significant growth during the forecast period. Use of topical drugs for treatment of dermatological fungal infections is a major driver for the anti-
fungal drugs market. Higher concentration of drugs can be applied to affected area and small number of doses is required for topical drug delivery. Based on distribution channel,
market is fragmented into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment is expected to hold lion’s share for the next five years as
large number of patients visit every day for treatment of various diseases. Increase in awareness regarding health and its benefits is also expected to boost the anti-fungal drugs
market growth.
Pfizer India Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd.,
Zydus Cadila Ltd., Novartis India Ltd., Torrent Pharmaceuticals Ltd. are the leading players operating in India anti-fungal drugs market. Manufacturers are increasingly focusing
on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several anti-fungal
drugs manufacturers are coming up with their technologically advanced offerings.
“Manufacturers are heavily investing to formulate advanced medication techniques for efficient treatment of anti-fungal diseases. Rise in use of nanotechnology for delivering
medicines with better outcomes such as treatment of nail fungus and launch of nanostructured drug delivery systems for treatment of vaginal and oral candidiasis is expected to
accelerate the demand for anti-fungal drugs. Government support for production of anti-fungal on a large scale for treatment of patients suffering from coronavirus is expected to
propel the growth of the anti-fungal drugs market until FY2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management
consulting firm.

13. 13
© TechSci Research
Sample Data - Snapshot
India Anti-Fungal Drugs Market Size, By Value (USD Million), FY2017-FY2027F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
FY2017 FY2021 FY2022E FY2027F
CAGR BY VALUE: XX% CAGR BY VALUE: XX%
India Anti-Fungal Drugs Market Share, By Drug Class, By Value, FY2017–FY2027F
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022E
FY2023F
FY2024F
FY2025F
FY2026F
FY2027F
Azoles Echinocandins Polyenes Allylamines Others
India Azoles Anti-Fungal Drugs Market Share, By Route of Administration, By Value, FY2017–FY2027F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022E
FY2023F
FY2024F
FY2025F
FY2026F
FY2027F
Parenteral Topical Oral Others

14. 14
© TechSci Research
Report Ordering
Report Name: INDIA ANTI-FUNGAL DRUGS MARKET
FORECAST & OPPORTUNITIES
FY2017 – FY2027
To View Sample OR Purchase Report
License Type Price
Single User License $3500
Multi-User License $4500
Custom Research License $7500

15. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• India Post COVID Health Tests Market By Type of Test (COVID-19 IgG Antibody Test, Hematology, Biochemistry Urea & Electrolytes, Liver
Function Tests, Kidney Function Tests, Others) By Provider Type (Hospitals, Diagnostic chains, Stand-alone Centre) By End User (Corporate
Clients, Walk-ins, Referrals) By Region, Competition Forecast & Opportunities, FY2027
• Asia-Pacific Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s Synthetic) By Source (Contact Manufacturing
Organizations v/s In-House Manufacturing) By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs,
Neurological Disorders, Musculoskeletal Disorders, Others) By Molecule Type (Small v/s Large) By Potency (Low v/s High) By Drug Type (Innovator
v/s Generics) By Country, Competition Forecast & Opportunities, 2026
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com